Control of Viral Load During Treatment Interruption of Antiretroviral Therapy Sustained and Ongoing for More than One Year in One Subject and Several Months in Another Additional Presentation Demonstrates Potential Mechanisms for Unprecedented HIV Reservoir Depletion by SB-728-T Sangamo BioSciences Announces Presentation At ICAAC of New Clinical Data Demonstrating Sustained Functional Control of Viremia in Multiple HIV-Infected Subjects Treated with SB-728-T Control of Viral Load During Treatment Interruption of Antiretroviral Therapy Sustained and Ongoing for More than One Year in One Subject and Several Months in Another /PRNewswire/ -- Sangamo BioSciences, Inc. announced the presentation of new data demonstrating that a single infusion of Sangamo's novel ZFP Therapeutic , SB-728-T, resulted in sustained reduction and control of viral load in the absence of antiretroviral drugs in ... (more)
http://ift.tt/WFfA6r
http://ift.tt/WFfA6r
No comments:
Post a Comment